334.18 4.02 (1.22%)
1.3M XNYS Volume
XNYS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 4,742 | 71,676 (0%) | 0% | 321.9 | 1,526,545 | Common Stock |
| Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,218 | 76,418 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,750 | 29,028 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 684 | 28,344 (0%) | 0% | 321.9 | 220,193 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 583 | 31,425 (0%) | 0% | 321.9 | 187,679 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,330 | 32,008 (0%) | 0% | 0 | Common Stock | |
| Christopher F. Wyatt | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 227 | 41,067 (0%) | 0% | 321.9 | 73,076 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 845 | 41,294 (0%) | 0% | 0 | Common Stock | |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 1,588 | 25,352 (0%) | 0% | 0 | Common Stock | |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 407 | 24,945 (0%) | 0% | 321.9 | 131,021 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 322.95 per share. | 13 Feb 2025 | 4,155 | 20,790 (0%) | 0% | 323.0 | 1,341,878 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 322.31 per share. | 13 Feb 2025 | 5,378 | 15,412 (0%) | 0% | 322.3 | 1,733,362 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 845 | 11,340 (0%) | 0% | 0 | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 227 | 11,113 (0%) | 0% | 321.9 | 73,076 | Common Stock |
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 531 | 2,696 (0%) | 0% | 321.9 | 170,940 | Common Stock |
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,117 | 3,227 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 638 | 638 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 172 | 466 (0%) | 0% | 321.9 | 55,370 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 7,440 | 0 | - | - | Stock Appreciation Right | |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 07 Feb 2025 | 7,440 | 26,171 (0%) | 0% | 101.2 | 752,630 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.06 per share. | 07 Feb 2025 | 4,340 | 30,511 (0%) | 0% | 139.1 | 603,520 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 322.05 per share. | 07 Feb 2025 | 6,747 | 23,764 (0%) | 0% | 322.0 | 2,172,871 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2025 | 4,340 | 0 | - | - | Stock Appreciation Right | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.29 per share. | 03 Feb 2025 | 41 | 10,495 (0%) | 0% | 334.3 | 13,706 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 138 | 10,536 (0%) | 0% | - | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 138 | 0 | - | - | Restricted Stock Units | |
| Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 74,620 | 74,620 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 16,756 | 16,756 | - | - | Stock Appreciation Right | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 11,171 | 11,171 | - | - | Stock Appreciation Right | |
| Christopher F. Wyatt | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 3,575 | 3,575 | - | - | Stock Appreciation Right | |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 8,490 | 8,490 | - | - | Stock Appreciation Right | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 4,469 | 4,469 | - | - | Stock Appreciation Right | |
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 11,171 | 11,171 | - | - | Stock Appreciation Right | |
| Mike A Marks | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 15,639 | 15,639 | - | - | Stock Appreciation Right | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 14 Nov 2024 | 1,474 | 9,454 (0%) | 0% | 358.0 | 527,677 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 12 Nov 2024 | 8,000 | 60,702 (0%) | 0% | 69.0 | 551,680 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 12 Nov 2024 | 8,000 | 0 | - | - | Stock Appreciation Right | ||
| Phillip G. Billington | SVP-Internal Audit Services | 12 Nov 2024 | 3,897 | 52,702 (0%) | 0% | 350 | 1,363,950 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 12 Nov 2024 | 4,103 | 56,599 (0%) | 0% | 350.5 | 1,438,225 | Common Stock | |
| Erol R Akdamar | Group President | 12 Nov 2024 | 10,257 | 9,743 (0%) | 0% | 350.5 | 3,595,386 | Common Stock | |
| Erol R Akdamar | Group President | 12 Nov 2024 | 20,000 | 20,000 (0%) | 0% | 69.0 | 1,379,200 | Common Stock | |
| Erol R Akdamar | Group President | 12 Nov 2024 | 2,900 | 6,843 (0%) | 0% | 353 | 1,023,700 | Common Stock | |
| Erol R Akdamar | Group President | 12 Nov 2024 | 20,000 | 0 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 11 Nov 2024 | 4,710 | 14,164 (0%) | 0% | 173.1 | 815,395 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 11 Nov 2024 | 3,236 | 10,928 (0%) | 0% | 358.0 | 1,158,456 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 11 Nov 2024 | 4,710 | 1,570 | - | - | Stock Appreciation Right | ||
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 244,626 | 404,512 (0%) | 0% | 361.6 | 88,444,543 | Common Stock, par value $0.01 per share |
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 638,573 | 9,668,536 (2%) | 0% | 361.6 | 230,876,417 | Common Stock, par value $0.01 per share |
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 244,626 | 9,029,962 (2%) | 0% | 361.6 | 88,444,543 | Common Stock, par value $0.01 per share |
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 138,000 | 264,216 (0%) | 0% | 361.6 | 49,893,900 | Common Stock, par value $0.01 per share |
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 638,573 | 0 (0%) | 0% | 361.6 | 230,876,417 | Common Stock, par value $0.01 per share |
| Patricia F Elcan | Ten Percent Owner | Other type of transaction at price $ 361.55 per share. | 30 Oct 2024 | 138,000 | 638,573 (0%) | 0% | 361.6 | 49,893,900 | Common Stock, par value $0.01 per share |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 22,080 | 0 | - | - | Stock Appreciation Right | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 385.42 per share. | 10 Sep 2024 | 8,358 | 29,678 (0%) | 0% | 385.4 | 3,221,340 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.43 per share. | 10 Sep 2024 | 13,722 | 38,036 (0%) | 0% | 386.4 | 5,302,592 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 145.24 per share. | 10 Sep 2024 | 22,080 | 51,758 (0%) | 0% | 145.2 | 3,206,899 | Common Stock |
| Mike A Marks | EVP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2024 | 2,237 | 43,227 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | EVP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2024 | 2,237 | 0 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 78,296 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 14,979 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 0 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 3,012 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 63,200 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 16,731 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 66,212 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 7,115 (0%) | 0% | 0 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 05 Aug 2024 | 13,367 | 18,526 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 05 Aug 2024 | 13,367 | 0 (0%) | 0% | 0 | Common Stock | ||
| Timothy M. McManus | Group President | 31 Jul 2024 | 3,919 | 27,008 (0%) | 0% | 363.1 | 1,422,793 | Common Stock | |
| Timothy M. McManus | Group President | 31 Jul 2024 | 7,500 | 30,927 (0%) | 0% | 77.1 | 578,475 | Common Stock | |
| Timothy M. McManus | Group President | 31 Jul 2024 | 7,500 | 7,440 | - | - | Stock Appreciation Right | ||
| Deborah M. Reiner | SVP - Mktg. & Communications | 29 Jul 2024 | 3,314 | 3,510 (0%) | 0% | 360.0 | 1,192,914 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 29 Jul 2024 | 5,293 | 14,305 (0%) | 0% | 358.7 | 1,898,758 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 29 Jul 2024 | 1,864 | 12,441 (0%) | 0% | 359.9 | 670,891 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 29 Jul 2024 | 2,987 | 9,454 (0%) | 0% | 363.5 | 1,085,804 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 29 Jul 2024 | 8,280 | 0 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 29 Jul 2024 | 8,280 | 19,598 (0%) | 0% | 145.2 | 1,202,587 | Common Stock | |
| Christopher F. Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 9,300 | 0 | - | - | Stock Appreciation Right | |
| Christopher F. Wyatt | SVP & Controller | Sale of securities on an exchange or to another person at price $ 360.20 per share. | 25 Jul 2024 | 4,000 | 40,449 (0%) | 0% | 360.2 | 1,440,782 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 352.79 per share. | 25 Jul 2024 | 5,278 | 44,449 (0%) | 0% | 352.8 | 1,862,026 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 25 Jul 2024 | 9,300 | 49,727 (0%) | 0% | 101.2 | 940,788 | Common Stock |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 Jul 2024 | 1,857 | 17,755 (0%) | 0% | 355.1 | 659,328 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 3,204 | 9,454 (0%) | 0% | 326.3 | 1,045,465 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 1,685 | 12,045 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 3,040 | 0 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 2,861 | 11,318 (0%) | 0% | 322.9 | 923,702 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 1,685 | 14,179 (0%) | 0% | 133.5 | 224,998 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 16 May 2024 | 3,040 | 12,494 (0%) | 0% | 101.2 | 307,526 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 9,908 | 13,367 (0%) | 0% | 327.0 | 3,239,520 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 19,000 | 0 | - | - | Stock Appreciation Right | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 19,000 | 23,275 (0%) | 0% | 69.0 | 1,310,240 | Common Stock | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 15 May 2024 | 27,510 | 61,295 (0%) | 0% | 82.0 | 2,254,720 | Common Stock |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 15 May 2024 | 11,955 | 33,785 (0%) | 0% | 69.6 | 831,829 | Common Stock |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 27,510 | 0 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 11,955 | 0 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 326.96 per share. | 15 May 2024 | 21,258 | 40,037 (0%) | 0% | 327.0 | 6,950,516 | Common Stock |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 15 May 2024 | 1,863 | 19,612 (0%) | 0% | 326.2 | 607,673 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 18,000 | 10,580 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 18,000 | 18,000 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 15 May 2024 | 36,600 | 47,180 (0%) | 0% | 101.2 | 3,702,456 | Common Stock |
| Jon M. Foster | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 345.51 per share. | 15 May 2024 | 20,902 | 26,278 (0%) | 0% | 345.5 | 7,221,850 | Common Stock |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 1,955 | 28,580 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Other type of transaction at price $ 352.74 per share. | 15 May 2024 | 9,502 | 64,560 (0%) | 0% | 352.7 | 3,351,735 | Common Stock |
| Jon M. Foster | EVP and COO | Other type of transaction at price $ 352.74 per share. | 15 May 2024 | 9,502 | 30,535 (0%) | 0% | 352.7 | 3,351,735 | Common Stock |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 5,350 | 54,308 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 5,350 | 0 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 36,600 | 0 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2024 | 1,955 | 66,515 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 316.88 per share. | 09 May 2024 | 6,311 | 29,623 (0%) | 0% | 316.9 | 1,999,825 | Common Stock |
| Jeffrey E. Cohen | SVP-Government Relations | 09 May 2024 | 1,650 | 5,185 (0%) | 0% | 313 | 516,450 | Common Stock | |
| Erol R Akdamar | Group President | 09 May 2024 | 5,139 | 0 (0%) | 0% | 0 | Common Stock | ||
| Erol R Akdamar | Group President | 09 May 2024 | 5,139 | 60,497 (0%) | 0% | 0 | Common Stock | ||
| Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 314.45 per share. | 06 May 2024 | 12,349 | 40,434 (0%) | 0% | 314.4 | 3,883,143 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 18,660 | 0 | - | - | Stock Appreciation Right | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2024 | 4,500 | 35,934 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.06 per share. | 06 May 2024 | 18,660 | 52,783 (0%) | 0% | 139.1 | 2,594,860 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 309.00 per share. | 06 May 2024 | 1,600 | 34,123 (0%) | 0% | 309 | 494,400 | Common Stock |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 02 May 2024 | 890 | 21,475 (0%) | 0% | 312 | 277,680 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 02 May 2024 | 973 | 22,365 (0%) | 0% | 312 | 303,576 | Common Stock | |
| Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 610 | 2,640 (0%) | 0% | 0 | Common Stock | |
| Nancy-Ann Deparle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 610 | 20,756 (0%) | 0% | 0 | Common Stock | |
| Michael W. Michelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 1,091 | 10,478 (0%) | 0% | 0 | Common Stock | |
| Wayne Joseph Riley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 610 | 13,875 (0%) | 0% | 0 | Common Stock | |
| Robert J. Dennis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 963 | 25,575 (0%) | 0% | 0 | Common Stock | |
| Thomas F. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 1,284 | 13,497 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| William R. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 963 | 11,905 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Andrea B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 610 | 3,512 (0%) | 0% | 0 | Common Stock | |
| Meg G. Crofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 610 | 6,331 (0%) | 0% | 0 | Common Stock | |
| Michael R. McAlevey | EVP - Chief Legal & Admin Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 2,274 | 2,274 | - | - | Stock Appreciation Right | |
| Mike A Marks | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2024 | 9,096 | 9,096 | - | - | Stock Appreciation Right | |
| Mike A Marks | EVP and CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Apr 2024 | 566 | 2,237 (0%) | 0% | 0 | Common Stock | |
| Chad J. Wasserman | SVP and CIO | 18 Mar 2024 | 344 | 2,452 (0%) | 0% | 322.0 | 110,758 | Common Stock | |
| Chad J. Wasserman | SVP and CIO | 18 Mar 2024 | 876 | 1,576 (0%) | 0% | 330.3 | 289,299 | Common Stock | |
| Chad J. Wasserman | SVP and CIO | 18 Mar 2024 | 2,100 | 4,190 | - | - | Stock Appreciation Right | ||
| Chad J. Wasserman | SVP and CIO | 18 Mar 2024 | 2,100 | 4,020 (0%) | 0% | 101.2 | 212,436 | Common Stock | |
| Chad J. Wasserman | SVP and CIO | 18 Mar 2024 | 1,224 | 2,796 (0%) | 0% | 327.2 | 400,456 | Common Stock | |
| Kathleen Whalen M. | SVP & Chief Ethics Officer | 16 Feb 2024 | 3,780 | 13,681 (0%) | 0% | 0 | Common Stock | ||
| A. Joseph Sowell | SVP; Chief Development Officer | 16 Feb 2024 | 6,280 | 6,280 (0%) | 0% | 0 | Common Stock | ||
| Jeffrey E. Cohen | SVP-Government Relations | 16 Feb 2024 | 1,359 | 6,835 (0%) | 0% | 308.5 | 419,319 | Common Stock | |
| Chad J. Wasserman | SVP and CIO | 16 Feb 2024 | 499 | 1,920 (0%) | 0% | 308.5 | 153,966 | Common Stock | |
| Sammie Mosier S. | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 1,620 | 11,466 (0%) | 0% | 0 | Common Stock | |
| Foster M. Jon | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 5,950 | 21,830 (0%) | 0% | 308.6 | 1,835,873 | Common Stock |
| Christopher Wyatt F. | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 5,020 | 42,403 (0%) | 0% | 0 | Common Stock | |
| Mosier Sammie S. | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 1,068 | 10,398 (0%) | 0% | 308.5 | 329,531 | Common Stock |
| McManus Timothy M. | Group President | 16 Feb 2024 | 6,280 | 25,429 (0%) | 0% | 0 | Common Stock | ||
| Erol Akdamar R | Group President | 16 Feb 2024 | 2,561 | 5,139 (0%) | 0% | 308.6 | 790,197 | Common Stock | |
| E. Jeffrey Cohen | SVP-Government Relations | 16 Feb 2024 | 3,780 | 8,194 (0%) | 0% | 0 | Common Stock | ||
| N. Hazen Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 78,440 | 296,131 (0%) | 0% | 0 | Common Stock | |
| F. Wyatt Christopher | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 1,976 | 40,427 (0%) | 0% | 308.6 | 609,695 | Common Stock |
| Whalen M. Kathleen | SVP & Chief Ethics Officer | 16 Feb 2024 | 1,023 | 12,658 (0%) | 0% | 308.6 | 315,647 | Common Stock | |
| Billington G. Phillip | SVP-Internal Audit Services | 16 Feb 2024 | 3,780 | 53,640 (0%) | 0% | 0 | Common Stock | ||
| Cuffe Michael S. | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 12,560 | 37,488 (0%) | 0% | 0 | Common Stock | |
| Wasserman Chad J. | SVP and CIO | 16 Feb 2024 | 2,040 | 2,419 (0%) | 0% | 0 | Common Stock | ||
| Samuel Hazen N. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 30,387 | 265,744 (0%) | 0% | 308.6 | 9,375,909 | Common Stock |
| Berres Jennifer L. | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 9,420 | 21,971 (0%) | 0% | 0 | Common Stock | |
| Reiner Deborah M. | SVP - Mktg. & Communications | 16 Feb 2024 | 1,510 | 6,824 (0%) | 0% | 308.6 | 465,911 | Common Stock | |
| William Rutherford B. | CFO and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 8,177 | 22,251 (0%) | 0% | 308.5 | 2,523,013 | Common Stock |
| A. Richard Hammett | Group President | 16 Feb 2024 | 5,500 | 19,698 (0%) | 0% | 0 | Common Stock | ||
| M. Deborah Reiner | SVP - Mktg. & Communications | 16 Feb 2024 | 5,020 | 8,334 (0%) | 0% | 0 | Common Stock | ||
| Sowell Joseph A. | SVP; Chief Development Officer | 16 Feb 2024 | 2,005 | 4,275 (0%) | 0% | 308.6 | 618,643 | Common Stock | |
| Marks A Mike | SVP-Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 3,780 | 3,825 (0%) | 0% | 0 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 16 Feb 2024 | 5,020 | 25,314 (0%) | 0% | 0 | Common Stock | ||
| B. Rutherford William | CFO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 21,980 | 30,428 (0%) | 0% | 0 | Common Stock | |
| M. Timothy McManus | Group President | 16 Feb 2024 | 2,002 | 23,427 (0%) | 0% | 308.5 | 617,717 | Common Stock | |
| Berres L. Jennifer | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 3,240 | 18,731 (0%) | 0% | 308.6 | 999,702 | Common Stock |
| R Erol Akdamar | Group President | 16 Feb 2024 | 7,700 | 7,700 (0%) | 0% | 0 | Common Stock | ||
| M. Jon Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 16,320 | 27,780 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | SVP-Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 1,022 | 2,803 (0%) | 0% | 308.5 | 315,338 | Common Stock |
| A. Richard Hammett | Group President | 16 Feb 2024 | 1,762 | 17,936 (0%) | 0% | 308.5 | 543,665 | Common Stock | |
| S. Mosier Sammie | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 2,200 | 9,846 (0%) | 0% | 0 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 16 Feb 2024 | 1,976 | 23,338 (0%) | 0% | 308.6 | 609,695 | Common Stock | |
| Billington Phillip G. | SVP-Internal Audit Services | 16 Feb 2024 | 1,022 | 52,618 (0%) | 0% | 308.5 | 315,338 | Common Stock | |
| S. Michael Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 6,212 | 35,696 (0%) | 0% | 308.6 | 1,916,713 | Common Stock |
| S. Cuffe Michael | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 4,420 | 41,908 (0%) | 0% | 0 | Common Stock | |
| M. Whalen Kathleen | SVP & Chief Ethics Officer | 14 Feb 2024 | 349 | 9,901 (0%) | 0% | 0 | Common Stock | ||
| Whalen Kathleen M. | SVP & Chief Ethics Officer | 09 Feb 2024 | 4,262 | 10,250 (0%) | 0% | 306.2 | 1,305,074 | Common Stock | |
| Torres A. Kathryn | SVP-Payer Contracting & Align. | 06 Feb 2024 | 2,092 | 21,717 (0%) | 0% | 173.1 | 362,167 | Common Stock | |
| Akdamar R Erol | Group President | 06 Feb 2024 | 12,874 | 55,358 (0%) | 0% | 0 | Common Stock | ||
| Akdamar Erol R | Group President | 06 Feb 2024 | 12,874 | 0 (0%) | 0% | 0 | Common Stock | ||
| A. Torres Kathryn | SVP-Payer Contracting & Align. | 06 Feb 2024 | 2,092 | 2,093 | - | - | Stock Appreciation Right | ||
| Kathryn Torres A. | SVP-Payer Contracting & Align. | 06 Feb 2024 | 1,423 | 20,294 (0%) | 0% | 306.8 | 436,605 | Common Stock | |
| Kathleen Whalen M. | SVP & Chief Ethics Officer | 05 Feb 2024 | 4,288 | 14,512 (0%) | 0% | 310.6 | 1,331,939 | Common Stock | |
| Wyatt F. Christopher | SVP & Controller | Sale of securities on an exchange or to another person at price $ 312.42 per share. | 05 Feb 2024 | 4,000 | 37,383 (0%) | 0% | 312.4 | 1,249,680 | Common Stock |
| M. Whalen Kathleen | SVP & Chief Ethics Officer | 05 Feb 2024 | 2,510 | 0 | - | - | Stock Appreciation Right | ||
| M. Kathleen Whalen | SVP & Chief Ethics Officer | 05 Feb 2024 | 4,040 | 0 | - | - | Stock Appreciation Right | ||
| Whalen Kathleen M. | SVP & Chief Ethics Officer | 05 Feb 2024 | 4,040 | 16,800 (0%) | 0% | 82.0 | 331,118 | Common Stock | |
| Whalen Kathleen M. | SVP & Chief Ethics Officer | 05 Feb 2024 | 2,000 | 3,040 | - | - | Stock Appreciation Right | ||
| M. Whalen Kathleen | SVP & Chief Ethics Officer | 05 Feb 2024 | 2,000 | 18,800 (0%) | 0% | 101.2 | 202,320 | Common Stock | |
| Whalen M. Kathleen | SVP & Chief Ethics Officer | 05 Feb 2024 | 2,510 | 12,760 (0%) | 0% | 69.6 | 174,646 | Common Stock | |
| Rutherford B. William | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Feb 2024 | 1,194 | 14,448 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Feb 2024 | 1,194 | 19,834 (0%) | 0% | 0 | Common Stock | |
| Mosier S. Sammie | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 309.42 per share. | 02 Feb 2024 | 5,127 | 9,188 (0%) | 0% | 309.4 | 1,586,396 | Common Stock |
| B. William Rutherford | CFO and EVP | Sale of securities on an exchange or to another person at price $ 310.63 per share. | 02 Feb 2024 | 6,000 | 8,448 (0%) | 0% | 310.6 | 1,863,780 | Common Stock |
| J. Wasserman Chad | SVP and CIO | 02 Feb 2024 | 38 | 379 (0%) | 0% | 309.4 | 11,758 | Common Stock | |
| Wasserman Chad J. | SVP and CIO | 02 Feb 2024 | 652 | 290 (0%) | 0% | 312.0 | 203,451 | Common Stock | |
| Chad Wasserman J. | SVP and CIO | 02 Feb 2024 | 127 | 128 | - | - | Restricted Stock Units | ||
| S. Sammie Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 236.61 per share. | 02 Feb 2024 | 2,775 | 13,052 (0%) | 0% | 236.6 | 656,593 | Common Stock |
| Sammie Mosier S. | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 253.30 per share. | 02 Feb 2024 | 1,263 | 14,315 (0%) | 0% | 253.3 | 319,918 | Common Stock |
| S. Sammie Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.12 per share. | 02 Feb 2024 | 920 | 8,937 (0%) | 0% | 173.1 | 159,270 | Common Stock |
| Chad J. Wasserman | SVP and CIO | 02 Feb 2024 | 127 | 417 (0%) | 0% | - | Common Stock | ||
| William Rutherford B. | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Feb 2024 | 175 | 15,642 (0%) | 0% | 0 | Common Stock | |
| Mosier Sammie S. | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 137 | 138 | - | - | Restricted Stock Units | |
| Mosier Sammie S. | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 137 | 9,325 (0%) | 0% | - | Common Stock | |
| Mosier S. Sammie | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 1,340 | 1,340 | - | - | Stock Appreciation Right | |
| Mosier S. Sammie | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 920 | 920 | - | - | Stock Appreciation Right | |
| Rutherford William B. | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 19,100 | 0 | - | - | Stock Appreciation Right | |
| Mosier Sammie S. | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 309.41 per share. | 02 Feb 2024 | 34 | 9,291 (0%) | 0% | 309.4 | 10,520 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 2,775 | 2,775 | - | - | Stock Appreciation Right | |
| William Rutherford B. | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 02 Feb 2024 | 19,100 | 25,469 (0%) | 0% | 69.6 | 1,328,978 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 1,263 | 3,789 | - | - | Stock Appreciation Right | |
| B. William Rutherford | CFO and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 309.42 per share. | 02 Feb 2024 | 9,652 | 15,817 (0%) | 0% | 309.4 | 2,986,522 | Common Stock |
| Sammie Mosier S. | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 241.81 per share. | 02 Feb 2024 | 1,340 | 10,277 (0%) | 0% | 241.8 | 324,025 | Common Stock |
| S. Sammie Mosier | SVP & Chief Nurse Executive | Sale of securities on an exchange or to another person at price $ 312.00 per share. | 02 Feb 2024 | 1,645 | 7,646 (0%) | 0% | 312 | 513,240 | Common Stock |
| Torres Kathryn A. | SVP-Payer Contracting & Align. | 31 Jan 2024 | 4,771 | 0 | - | - | Stock Appreciation Right | ||
| Torres A. Kathryn | SVP-Payer Contracting & Align. | 31 Jan 2024 | 1,263 | 28,893 (0%) | 0% | 253.3 | 319,918 | Common Stock | |
| E. Cohen Jeffrey | SVP-Government Relations | 31 Jan 2024 | 3,302 | 3,302 | - | - | Stock Appreciation Right | ||
| M. Jon Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 20,634 | 20,634 | - | - | Stock Appreciation Right | |
| Hazen N. Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,784 | 79,784 | - | - | Stock Appreciation Right | |
| F. Christopher Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 31 Jan 2024 | 9,000 | 47,759 (0%) | 0% | 101.2 | 910,440 | Common Stock |
| L. Berres Jennifer | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 9,354 | 9,354 | - | - | Stock Appreciation Right | |
| F. Christopher Wyatt | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 31 Jan 2024 | 4,185 | 4,185 | - | - | Stock Appreciation Right | ||
| Christopher Wyatt F. | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 304.90 per share. | 31 Jan 2024 | 6,376 | 41,383 (0%) | 0% | 304.9 | 1,944,042 | Common Stock |
| F. Christopher Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 9,000 | 9,300 | - | - | Stock Appreciation Right | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 31 Jan 2024 | 3,861 | 15,899 (0%) | 0% | 307 | 1,185,327 | Common Stock | |
| S. Michael Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 306.79 per share. | 31 Jan 2024 | 3,200 | 24,928 (0%) | 0% | 306.8 | 981,734 | Common Stock |
| Timothy McManus M | Group President | 31 Jan 2024 | 11,005 | 11,005 | - | - | Stock Appreciation Right | ||
| Cuffe Michael S. | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 12,656 | 12,656 | - | - | Stock Appreciation Right | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 31 Jan 2024 | 4,771 | 20,670 (0%) | 0% | 145.2 | 692,940 | Common Stock | |
| M. Whalen Kathleen | SVP & Chief Ethics Officer | 31 Jan 2024 | 3,302 | 3,302 | - | - | Stock Appreciation Right | ||
| A. Torres Kathryn | SVP-Payer Contracting & Align. | 31 Jan 2024 | 1,263 | 3,789 | - | - | Stock Appreciation Right | ||
| Mosier Sammie S. | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | |
| Hammett A Richard | Group President | 31 Jan 2024 | 11,005 | 11,005 | - | - | Stock Appreciation Right | ||
| Torres A. Kathryn | SVP-Payer Contracting & Align. | 31 Jan 2024 | 9,268 | 19,625 (0%) | 0% | 314.7 | 2,916,269 | Common Stock | |
| Reiner M. Deborah | SVP - Mktg. & Communications | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | ||
| Torres A. Kathryn | SVP-Payer Contracting & Align. | 31 Jan 2024 | 2,775 | 27,630 (0%) | 0% | 236.6 | 656,593 | Common Stock | |
| Rutherford B. William | CFO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 20,634 | 20,634 | - | - | Stock Appreciation Right | |
| Akdamar R Erol | Group President | 31 Jan 2024 | 11,005 | 11,005 | - | - | Stock Appreciation Right | ||
| A Marks Mike | SVP-Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 5,503 | 5,503 | - | - | Stock Appreciation Right | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | ||
| R. McAlevey Michael | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 11,005 | 11,005 | - | - | Stock Appreciation Right | |
| Phillip Billington G. | SVP-Internal Audit Services | 31 Jan 2024 | 3,302 | 3,302 | - | - | Stock Appreciation Right | ||
| Torres A. Kathryn | SVP-Payer Contracting & Align. | 31 Jan 2024 | 4,185 | 24,855 (0%) | 0% | 173.1 | 724,507 | Common Stock | |
| Christopher F. Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 2,680 | 0 | - | - | Stock Appreciation Right | |
| Sowell A. Joseph | SVP; Chief Development Officer | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | ||
| F. Wyatt Christopher | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 31 Jan 2024 | 2,680 | 38,759 (0%) | 0% | 82.0 | 219,653 | Common Stock |
| Kathryn Torres A. | SVP-Payer Contracting & Align. | 31 Jan 2024 | 2,775 | 2,775 | - | - | Stock Appreciation Right | ||
| S. Cuffe Michael | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Jan 2024 | 728 | 28,128 (0%) | 0% | 0 | Common Stock | |
| Hammett Richard A | Group President | 29 Jan 2024 | 164 | 14,198 (0%) | 0% | 286.7 | 47,024 | Common Stock | |
| Richard Hammett A | Group President | 29 Jan 2024 | 600 | 14,362 (0%) | 0% | - | Common Stock | ||
| Richard Hammett A | Group President | 29 Jan 2024 | 600 | 0 | - | - | Restricted Stock Units | ||
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.73 per share. | 29 Jan 2024 | 96 | 8,017 (0%) | 0% | 286.7 | 27,526 | Common Stock |
| S. Sammie Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 323 | 0 | - | - | Restricted Stock Units | |
| S. Mosier Sammie | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 323 | 8,113 (0%) | 0% | - | Common Stock | |
| R. McAlevey Michael | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,940 | 4,501 (0%) | 0% | - | Common Stock | |
| McAlevey R. Michael | SVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 283.43 per share. | 28 Jan 2024 | 489 | 4,012 (0%) | 0% | 283.4 | 138,597 | Common Stock |
| McAlevey R. Michael | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,940 | 0 | - | - | Restricted Stock Units | |
| Erol R Akdamar | Group President | 13 Nov 2023 | 26,825 | 26,825 (0%) | 0% | 48.0 | 1,286,795 | Common Stock | |
| Erol R Akdamar | Group President | 13 Nov 2023 | 12,325 | 0 | - | - | Stock Appreciation Right | ||
| Erol R Akdamar | Group President | 13 Nov 2023 | 14,500 | 0 | - | - | Stock Appreciation Right | ||
| Erol R Akdamar | Group President | 13 Nov 2023 | 13,951 | 12,874 (0%) | 0% | 230.0 | 3,208,590 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 0 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 5,159 | 0 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 5,159 | 5,159 (0%) | 0% | 0 | Common Stock | ||
| Phillip G. Billington | SVP-Internal Audit Services | 10 Nov 2023 | 5,525 | 0 | - | - | Stock Appreciation Right | ||
| Phillip G. Billington | SVP-Internal Audit Services | 10 Nov 2023 | 6,500 | 0 | - | - | Stock Appreciation Right | ||
| Phillip G. Billington | SVP-Internal Audit Services | 10 Nov 2023 | 6,237 | 49,860 (0%) | 0% | 232.8 | 1,452,098 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 10 Nov 2023 | 12,025 | 56,097 (0%) | 0% | 48.0 | 576,839 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2023 | 40,500 | 40,500 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2023 | 40,500 | 6,369 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2023 | 49,500 | 90,000 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Aug 2023 | 49,500 | 0 (0%) | 0% | 0 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 14 Aug 2023 | 5,204 | 19,760 (0%) | 0% | 269.1 | 1,400,516 | Common Stock | |
| Jeffrey E. Cohen | SVP-Government Relations | 11 Aug 2023 | 1,500 | 4,414 (0%) | 0% | 270 | 405,000 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 03 Aug 2023 | 2,916 | 10,250 (0%) | 0% | 270 | 787,320 | Common Stock | |
| Mike A Marks | SVP-Finance | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Aug 2023 | 8,343 | 40,990 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | SVP-Finance | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Aug 2023 | 205 | 45 (0%) | 0% | 0 | Common Stock | |
| Mike A Marks | SVP-Finance | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Aug 2023 | 8,343 | 250 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2023 | 49,500 | 49,500 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Aug 2023 | 49,500 | 46,869 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2023 | 6,100 | 16,810 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2023 | 5,350 | 5,350 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2023 | 5,350 | 11,460 (0%) | 0% | 0 | Common Stock | |
| Jon M. Foster | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2023 | 6,100 | 55,058 (0%) | 0% | 0 | Common Stock | |
| Richard A Hammett | Group President | 12 May 2023 | 1,100 | 13,762 (0%) | 0% | 0 | Common Stock | ||
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 155,923 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 4,647 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 151,276 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 7,864 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 284.44 per share. | 28 Apr 2023 | 12,556 | 28,783 (0%) | 0% | 284.4 | 3,571,396 | Common Stock |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 28 Apr 2023 | 3,509 | 4,771 | - | - | Stock Appreciation Right | ||
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 28 Apr 2023 | 5,335 | 0 | - | - | Stock Appreciation Right | ||
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 28 Apr 2023 | 6,123 | 24,964 (0%) | 0% | 287.3 | 1,759,322 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 28 Apr 2023 | 3,509 | 31,087 (0%) | 0% | 145.2 | 509,647 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 28 Apr 2023 | 5,335 | 27,578 (0%) | 0% | 139.1 | 741,885 | Common Stock | |
| Erol R Akdamar | Group President | 28 Apr 2023 | 42,484 | 0 (0%) | 0% | 0 | Common Stock | ||
| Erol R Akdamar | Group President | 28 Apr 2023 | 42,484 | 42,484 (0%) | 0% | 0 | Common Stock | ||
| Erol R Akdamar | Group President | 28 Apr 2023 | 3,500 | 42,484 (0%) | 0% | 285 | 997,500 | Common Stock | |
| Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 663 | 2,030 (0%) | 0% | 0 | Common Stock | |
| Nancy-Ann Deparle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 663 | 20,146 (0%) | 0% | 0 | Common Stock | |
| Michael W. Michelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 1,187 | 9,387 (0%) | 0% | 0 | Common Stock | |
| Wayne Joseph Riley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 663 | 13,265 (0%) | 0% | 0 | Common Stock | |
| Robert J. Dennis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 1,047 | 24,612 (0%) | 0% | 0 | Common Stock | |
| Thomas F. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 1,396 | 12,213 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| William R. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 1,047 | 10,942 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Andrea B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 663 | 2,902 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 286.25 per share. | 24 Apr 2023 | 19,464 | 41,339 (0%) | 0% | 286.3 | 5,571,570 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 24 Apr 2023 | 32,020 | 60,803 (0%) | 0% | 101.2 | 3,239,143 | Common Stock |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 32,020 | 0 | - | - | Stock Appreciation Right | |
| Meg G. Crofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 663 | 5,721 (0%) | 0% | 0 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 24 Apr 2023 | 4,473 | 22,243 (0%) | 0% | 288.4 | 1,289,913 | Common Stock | |
| P. Martin Paslick | SVP and CIO | Sale of securities on an exchange or to another person at price $ 275.00 per share. | 12 Apr 2023 | 2,687 | 24,643 (0%) | 0% | 275 | 738,925 | Common Stock |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 12 Apr 2023 | 6,340 | 30,983 (0%) | 0% | 82.0 | 519,626 | Common Stock |
| P. Martin Paslick | SVP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.38 per share. | 12 Apr 2023 | 3,653 | 27,330 (0%) | 0% | 272.4 | 995,004 | Common Stock |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 6,340 | 0 | - | - | Stock Appreciation Right | |
| P. Martin Paslick | SVP and CIO | Sale of securities on an exchange or to another person at price $ 270.00 per share. | 10 Apr 2023 | 2,539 | 24,643 (0%) | 0% | 270 | 685,530 | Common Stock |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 04 Apr 2023 | 6,000 | 30,643 (0%) | 0% | 82.0 | 491,760 | Common Stock |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2023 | 6,000 | 6,340 | - | - | Stock Appreciation Right | |
| P. Martin Paslick | SVP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.31 per share. | 04 Apr 2023 | 3,461 | 27,182 (0%) | 0% | 271.3 | 939,004 | Common Stock |
| P. Martin Paslick | SVP and CIO | Sale of securities on an exchange or to another person at price $ 265.00 per share. | 04 Apr 2023 | 3,034 | 24,643 (0%) | 0% | 265 | 804,010 | Common Stock |
| William B. Rutherford | CFO and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 9,563 | 96,369 (0%) | 0% | 262.8 | 2,513,539 | Common Stock |
| William B. Rutherford | CFO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 24,300 | 105,932 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 94,880 | 200,557 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 36,770 | 163,787 (0%) | 0% | 262.8 | 9,664,627 | Common Stock |
| Joseph A. Sowell | SVP; Chief Development Officer | 17 Feb 2023 | 7,600 | 7,600 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 17 Feb 2023 | 2,441 | 5,159 (0%) | 0% | 262.8 | 641,592 | Common Stock | |
| Jon M. Foster | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 7,768 | 22,910 (0%) | 0% | 262.8 | 2,041,741 | Common Stock |
| Jon M. Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 19,740 | 30,678 (0%) | 0% | 0 | Common Stock | |
| P. Martin Paslick | SVP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 3,589 | 27,677 (0%) | 0% | 262.8 | 943,333 | Common Stock |
| P. Martin Paslick | SVP and CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 9,120 | 31,266 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 12,160 | 32,982 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 4,232 | 28,750 (0%) | 0% | 262.8 | 1,112,339 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 2,393 | 36,079 (0%) | 0% | 262.8 | 628,976 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 6,080 | 38,472 (0%) | 0% | 0 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 17 Feb 2023 | 6,080 | 28,560 (0%) | 0% | 0 | Common Stock | ||
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 17 Feb 2023 | 1,844 | 26,716 (0%) | 0% | 262.8 | 484,677 | Common Stock | |
| Deborah M. Reiner | SVP - Mktg. & Communications | 17 Feb 2023 | 4,560 | 4,560 (0%) | 0% | 0 | Common Stock | ||
| Deborah M. Reiner | SVP - Mktg. & Communications | 17 Feb 2023 | 1,246 | 3,314 (0%) | 0% | 262.8 | 327,499 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 17 Feb 2023 | 4,560 | 45,212 (0%) | 0% | 0 | Common Stock | ||
| Phillip G. Billington | SVP-Internal Audit Services | 17 Feb 2023 | 1,247 | 43,965 (0%) | 0% | 262.8 | 327,761 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 17 Feb 2023 | 4,560 | 14,522 (0%) | 0% | 0 | Common Stock | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 17 Feb 2023 | 1,734 | 9,962 (0%) | 0% | 263.6 | 457,097 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 17 Feb 2023 | 1,356 | 13,166 (0%) | 0% | 262.8 | 356,411 | Common Stock | |
| Jeffrey E. Cohen | SVP-Government Relations | 17 Feb 2023 | 1,652 | 5,914 (0%) | 0% | 262.8 | 434,212 | Common Stock | |
| Jeffrey E. Cohen | SVP-Government Relations | 17 Feb 2023 | 4,560 | 7,566 (0%) | 0% | 0 | Common Stock | ||
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 2,441 | 12,551 (0%) | 0% | 262.8 | 641,592 | Common Stock |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 7,600 | 14,992 (0%) | 0% | 0 | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 273 | 7,790 (0%) | 0% | 262.8 | 71,755 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 1,120 | 8,063 (0%) | 0% | 0 | Common Stock | |
| Erol R Akdamar | Group President | 17 Feb 2023 | 3,110 | 45,984 (0%) | 0% | 262.8 | 817,432 | Common Stock | |
| Erol R Akdamar | Group President | 17 Feb 2023 | 9,300 | 49,094 (0%) | 0% | 0 | Common Stock | ||
| Richard A Hammett | Group President | 17 Feb 2023 | 7,620 | 18,276 (0%) | 0% | 0 | Common Stock | ||
| Richard A Hammett | Group President | 17 Feb 2023 | 2,060 | 10,656 (0%) | 0% | 0 | Common Stock | ||
| Richard A Hammett | Group President | 17 Feb 2023 | 3,414 | 14,862 (0%) | 0% | 262.8 | 897,336 | Common Stock | |
| Mike A Marks | SVP-Finance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 1,847 | 8,593 (0%) | 0% | 262.8 | 485,465 | Common Stock |
| Mike A Marks | SVP-Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 6,080 | 10,440 (0%) | 0% | 0 | Common Stock | |
| Timothy M McManus | Group President | 17 Feb 2023 | 2,438 | 19,149 (0%) | 0% | 262.8 | 640,804 | Common Stock | |
| Timothy M McManus | Group President | 17 Feb 2023 | 7,600 | 21,587 (0%) | 0% | 0 | Common Stock | ||
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 16 Feb 2023 | 2,467 | 22,480 (0%) | 0% | 263.1 | 649,191 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 16 Feb 2023 | 4,575 | 24,947 (0%) | 0% | 101.2 | 462,807 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 16 Feb 2023 | 4,575 | 0 | - | - | Stock Appreciation Right | ||
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 255.23 per share. | 07 Feb 2023 | 4,000 | 7,392 (0%) | 0% | 255.2 | 1,020,912 | Common Stock |
| Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 03 Feb 2023 | 59,000 | 137,885 (0%) | 0% | 69.0 | 4,068,640 | Common Stock |
| Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.08 per share. | 03 Feb 2023 | 32,208 | 105,677 (0%) | 0% | 258.1 | 8,312,241 | Common Stock |
| Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 59,000 | 0 | - | - | Stock Appreciation Right | |
| Deborah M. Reiner | SVP - Mktg. & Communications | 03 Feb 2023 | 7,941 | 0 (0%) | 0% | 257.6 | 2,045,699 | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 138 | 275 | - | - | Restricted Stock Units | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 138 | 6,984 (0%) | 0% | - | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.07 per share. | 03 Feb 2023 | 41 | 6,943 (0%) | 0% | 258.1 | 10,581 | Common Stock |
| Erol R Akdamar | Group President | 02 Feb 2023 | 9,000 | 0 | - | - | Stock Appreciation Right | ||
| Erol R Akdamar | Group President | 02 Feb 2023 | 3,000 | 34,726 (0%) | 0% | 258.6 | 775,891 | Common Stock | |
| Erol R Akdamar | Group President | 02 Feb 2023 | 9,000 | 43,726 (0%) | 0% | 45.3 | 407,700 | Common Stock | |
| Erol R Akdamar | Group President | 02 Feb 2023 | 3,932 | 39,794 (0%) | 0% | 258.1 | 1,014,771 | Common Stock | |
| William B. Rutherford | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 27,000 | 19,100 | - | - | Stock Appreciation Right | |
| William B. Rutherford | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 37,000 | 0 | - | - | Stock Appreciation Right | |
| William B. Rutherford | CFO and EVP | Sale of securities on an exchange or to another person at price $ 258.19 per share. | 01 Feb 2023 | 30,000 | 81,632 (0%) | 0% | 258.2 | 7,745,568 | Common Stock |
| William B. Rutherford | CFO and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 261.46 per share. | 01 Feb 2023 | 34,895 | 111,632 (0%) | 0% | 261.5 | 9,123,647 | Common Stock |
| William B. Rutherford | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 01 Feb 2023 | 27,000 | 146,527 (0%) | 0% | 69.6 | 1,878,660 | Common Stock |
| William B. Rutherford | CFO and EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 01 Feb 2023 | 37,000 | 119,527 (0%) | 0% | 69.0 | 2,551,520 | Common Stock |
| William B. Rutherford | CFO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 23,680 | 23,680 | - | - | Stock Appreciation Right | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 450 | 82,527 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 18,640 | 18,640 (0%) | 0% | 0 | Common Stock | |
| William B. Rutherford | CFO and EVP | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 18,640 | 0 (0%) | 0% | 0 | Common Stock | |
| Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 82,880 | 82,880 | - | - | Stock Appreciation Right | |
| Joseph A. Sowell | SVP; Chief Development Officer | 30 Jan 2023 | 6,315 | 6,315 | - | - | Stock Appreciation Right | ||
| Jon M. Foster | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 23,680 | 23,680 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 30 Jan 2023 | 11,955 | 46,893 (0%) | 0% | 69.6 | 831,829 | Common Stock |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 30 Jan 2023 | 24,000 | 34,938 (0%) | 0% | 69.0 | 1,655,040 | Common Stock |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 24,000 | 0 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 11,955 | 11,955 | - | - | Stock Appreciation Right | |
| Jon M. Foster | EVP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.30 per share. | 30 Jan 2023 | 19,531 | 27,362 (0%) | 0% | 253.3 | 4,947,202 | Common Stock |
| Jon M. Foster | EVP and COO | Sale of securities on an exchange or to another person at price $ 251.98 per share. | 30 Jan 2023 | 16,424 | 10,938 (0%) | 0% | 252.0 | 4,138,480 | Common Stock |
| P. Martin Paslick | SVP and CIO | Sale of securities on an exchange or to another person at price $ 256.95 per share. | 30 Jan 2023 | 1,000 | 3,000 (0%) | 0% | 256.9 | 256,949 | Common Stock |
| P. Martin Paslick | SVP and CIO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 9,472 | 9,472 | - | - | Stock Appreciation Right | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 450 | 24,822 (0%) | 0% | 0 | Common Stock | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 14,524 | 14,524 | - | - | Stock Appreciation Right | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | Sale of securities on an exchange or to another person at price $ 257.11 per share. | 30 Jan 2023 | 4,000 | 20,822 (0%) | 0% | 257.1 | 1,028,440 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Jan 2023 | 379 | 37,292 (0%) | 0% | 0 | Common Stock | |
| Christopher F. Wyatt | SVP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 5,052 | 5,052 | - | - | Stock Appreciation Right | |
| Christopher F. Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 12,000 | 2,680 | - | - | Stock Appreciation Right | |
| Christopher F. Wyatt | SVP & Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 30 Jan 2023 | 12,000 | 44,184 (0%) | 0% | 82.0 | 983,520 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.30 per share. | 30 Jan 2023 | 6,513 | 37,671 (0%) | 0% | 253.3 | 1,649,743 | Common Stock |
| Christopher F. Wyatt | SVP & Controller | Sale of securities on an exchange or to another person at price $ 253.30 per share. | 30 Jan 2023 | 4,900 | 32,392 (0%) | 0% | 253.3 | 1,241,170 | Common Stock |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 30 Jan 2023 | 5,052 | 5,052 | - | - | Stock Appreciation Right | ||
| Deborah M. Reiner | SVP - Mktg. & Communications | 30 Jan 2023 | 5,052 | 5,052 | - | - | Stock Appreciation Right | ||
| Phillip G. Billington | SVP-Internal Audit Services | 30 Jan 2023 | 3,789 | 3,789 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 30 Jan 2023 | 1,250 | 12,282 (0%) | 0% | 69.6 | 86,975 | Common Stock | |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 30 Jan 2023 | 341 | 11,032 (0%) | 0% | 0 | Common Stock | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 30 Jan 2023 | 1,250 | 2,510 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 30 Jan 2023 | 3,789 | 3,789 | - | - | Stock Appreciation Right | ||
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 30 Jan 2023 | 586 | 11,696 (0%) | 0% | 255.1 | 149,471 | Common Stock | |
| Jeffrey E. Cohen | SVP-Government Relations | 30 Jan 2023 | 3,789 | 3,789 | - | - | Stock Appreciation Right | ||
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 10,735 | 10,735 | - | - | Stock Appreciation Right | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 5,052 | 5,052 | - | - | Stock Appreciation Right | |
| Michael R. McAlevey | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 12,630 | 12,630 | - | - | Stock Appreciation Right | |
| Erol R Akdamar | Group President | 30 Jan 2023 | 17,051 | 17,051 | - | - | Stock Appreciation Right | ||
| Richard A Hammett | Group President | 30 Jan 2023 | 17,051 | 17,051 | - | - | Stock Appreciation Right | ||
| Mike A Marks | SVP-Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 7,578 | 7,578 | - | - | Stock Appreciation Right | |
| Timothy M McManus | Group President | 30 Jan 2023 | 7,800 | 14,087 (0%) | 0% | 254.1 | 1,981,607 | Common Stock | |
| Timothy M McManus | Group President | 30 Jan 2023 | 17,051 | 17,051 | - | - | Stock Appreciation Right | ||
| Timothy M McManus | Group President | 30 Jan 2023 | 100 | 13,987 (0%) | 0% | 254.6 | 25,460 | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 273 | 6,920 (0%) | 0% | - | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 273 | 0 | - | - | Restricted Stock Units | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.77 per share. | 29 Jan 2023 | 96 | 6,647 (0%) | 0% | 254.8 | 24,458 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 322 | 6,743 (0%) | 0% | - | Common Stock | |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.30 per share. | 29 Jan 2023 | 74 | 6,846 (0%) | 0% | 253.3 | 18,744 | Common Stock |
| Sammie S. Mosier | SVP & Chief Nurse Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 322 | 323 | - | - | Restricted Stock Units | |
| Richard A Hammett | Group President | 29 Jan 2023 | 600 | 8,309 (0%) | 0% | - | Common Stock | ||
| Richard A Hammett | Group President | 29 Jan 2023 | 598 | 0 | - | - | Restricted Stock Units | ||
| Richard A Hammett | Group President | 29 Jan 2023 | 600 | 600 | - | - | Restricted Stock Units | ||
| Richard A Hammett | Group President | 29 Jan 2023 | 146 | 8,596 (0%) | 0% | 253.3 | 36,982 | Common Stock | |
| Richard A Hammett | Group President | 29 Jan 2023 | 598 | 8,742 (0%) | 0% | - | Common Stock | ||
| Richard A Hammett | Group President | 29 Jan 2023 | 165 | 8,144 (0%) | 0% | 254.8 | 42,037 | Common Stock | |
| Michael R. McAlevey | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2023 | 1,940 | 1,940 | - | - | Restricted Stock Units | |
| Michael R. McAlevey | SVP & Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2023 | 1,940 | 3,050 (0%) | 0% | - | Common Stock | |
| Michael R. McAlevey | SVP & Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.77 per share. | 28 Jan 2023 | 489 | 2,561 (0%) | 0% | 254.8 | 124,583 | Common Stock |
| P. Martin Paslick | SVP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 263.81 per share. | 23 Jan 2023 | 2,966 | 22,146 (0%) | 0% | 263.8 | 782,460 | Common Stock |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 6,000 | 12,340 | - | - | Stock Appreciation Right | |
| P. Martin Paslick | SVP and CIO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 23 Jan 2023 | 6,000 | 25,112 (0%) | 0% | 82.0 | 491,760 | Common Stock |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 145.24 per share. | 11 Nov 2022 | 12,000 | 211,883 (0%) | 0% | 145.2 | 1,742,880 | Common Stock |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2022 | 12,000 | 23,880 | - | - | Stock Appreciation Right | |
| Charles J. Hall | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.08 per share. | 11 Nov 2022 | 9,440 | 202,443 (0%) | 0% | 224.1 | 2,115,315 | Common Stock |
| A. Bruce Moore | Group President - Service Line | Sale of securities on an exchange or to another person at price $ 224.07 per share. | 11 Nov 2022 | 10,000 | 30,807 (0%) | 0% | 224.1 | 2,240,690 | Common Stock |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.06 per share. | 28 Oct 2022 | 21,997 | 232,785 (0%) | 0% | 139.1 | 3,058,903 | Common Stock |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 21,997 | 7,333 | - | - | Stock Appreciation Right | |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2022 | 9,150 | 0 | - | - | Stock Appreciation Right | |
| Charles J. Hall | Group President | Sale of securities on an exchange or to another person at price $ 223.50 per share. | 28 Oct 2022 | 9,838 | 199,883 (0%) | 0% | 223.5 | 2,198,793 | Common Stock |
| Charles J. Hall | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.66 per share. | 28 Oct 2022 | 23,064 | 209,721 (0%) | 0% | 223.7 | 5,158,494 | Common Stock |
| Charles J. Hall | Group President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.16 per share. | 28 Oct 2022 | 9,150 | 210,788 (0%) | 0% | 101.2 | 925,614 | Common Stock |
| Joseph A. Sowell | SVP; Chief Development Officer | 28 Oct 2022 | 12,946 | 0 (0%) | 0% | 223.2 | 2,889,304 | Common Stock | |
| A. Bruce Moore | Group President - Service Line | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2022 | 35,625 | 0 | - | - | Stock Appreciation Right | |
| A. Bruce Moore | Group President - Service Line | Payment of exercise price or tax liability using portion of securities received from the company at price $ 217.77 per share. | 27 Oct 2022 | 17,709 | 40,807 (0%) | 0% | 217.8 | 3,856,489 | Common Stock |
| A. Bruce Moore | Group President - Service Line | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.18 per share. | 27 Oct 2022 | 35,625 | 58,516 (0%) | 0% | 37.2 | 1,324,538 | Common Stock |
| Phillip G. Billington | SVP-Internal Audit Services | 26 Oct 2022 | 8,500 | 0 | - | - | Stock Appreciation Right | ||
| Phillip G. Billington | SVP-Internal Audit Services | 26 Oct 2022 | 8,332 | 40,652 (0%) | 0% | 222.6 | 1,854,518 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 26 Oct 2022 | 8,243 | 48,984 (0%) | 0% | 217.5 | 1,792,688 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 26 Oct 2022 | 16,575 | 57,227 (0%) | 0% | 37.2 | 616,259 | Common Stock | |
| Phillip G. Billington | SVP-Internal Audit Services | 26 Oct 2022 | 8,075 | 0 | - | - | Stock Appreciation Right | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 3,600 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 17,051 | 33,371 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 5,000 | 16,320 (0%) | 0% | 0 | Common Stock | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 27,500 | 0 | - | - | Stock Appreciation Right | ||
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 14,554 | 12,946 (0%) | 0% | 214.4 | 3,120,378 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 27,500 | 27,500 (0%) | 0% | 48.0 | 1,319,175 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 17,051 | 0 (0%) | 0% | 0 | Common Stock | ||
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 24 Oct 2022 | 300 | 20,372 (0%) | 0% | 209.9 | 62,982 | Common Stock | |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 24 Oct 2022 | 1,700 | 20,672 (0%) | 0% | 202.1 | 343,623 | Common Stock | |
| Patricia F Elcan | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 198.66 per share. | 25 Jul 2022 | 325 | 89,337 (0%) | 0% | 198.7 | 64,565 | Common Stock, par value $0.01 per share |
| Jennifer L. Berres | SVP & Chief Human Res. Officer | Sale of securities on an exchange or to another person at price $ 218.87 per share. | 13 May 2022 | 2,358 | 11,392 (0%) | 0% | 218.9 | 516,086 | Common Stock |
| Kathleen M. Whalen | SVP & Chief Ethics Officer | 03 May 2022 | 500 | 11,373 (0%) | 0% | 215.4 | 107,690 | Common Stock | |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 215.29 per share. | 02 May 2022 | 7,577 | 478,955 (0%) | 0% | 215.3 | 1,631,279 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 214.48 per share. | 02 May 2022 | 12,170 | 471,378 (0%) | 0% | 214.5 | 2,610,270 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 213.47 per share. | 02 May 2022 | 7,683 | 459,208 (0%) | 0% | 213.5 | 1,640,067 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 212.60 per share. | 02 May 2022 | 3,606 | 451,525 (0%) | 0% | 212.6 | 766,632 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 211.22 per share. | 02 May 2022 | 16,313 | 447,919 (0%) | 0% | 211.2 | 3,445,589 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 209.73 per share. | 02 May 2022 | 4,128 | 393,983 (0%) | 0% | 209.7 | 865,760 | Common Stock, par value $0.01 per share |
| Thomas F. Frist | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 210.60 per share. | 02 May 2022 | 37,623 | 431,606 (0%) | 0% | 210.6 | 7,923,404 | Common Stock, par value $0.01 per share |
| Michael R. McAlevey | SVP & Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 218.56 per share. | 29 Apr 2022 | 1,110 | 1,110 (0%) | 0% | 218.6 | 242,602 | Common Stock |
| Andrea B. Smith | Director | Purchase of securities on an exchange or from another person at price $ 213.63 per share. | 28 Apr 2022 | 1,160 | 2,239 (0%) | 0% | 213.6 | 247,815 | Common Stock |
| Charles O. Holliday | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 18,955 (0%) | 0% | 0 | Common Stock | |
| Hugh F. Johnston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 1,367 (0%) | 0% | 0 | Common Stock | |
| Nancy-Ann Deparle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 19,483 (0%) | 0% | 0 | Common Stock | |
| Michael W. Michelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 1,424 | 8,200 (0%) | 0% | 0 | Common Stock | |
| Wayne Joseph Riley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 12,602 (0%) | 0% | 0 | Common Stock | |
| Robert J. Dennis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 23,565 (0%) | 0% | 0 | Common Stock | |
| Thomas F. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 1,899 | 10,817 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| William R. Frist | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 1,424 | 9,895 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Andrea B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 1,079 (0%) | 0% | 0 | Common Stock | |
| Meg G. Crofton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 902 | 5,058 (0%) | 0% | 0 | Common Stock | |
| Joseph A. Sowell | SVP; Chief Development Officer | 11 Mar 2022 | 11,522 | 17,051 (0%) | 0% | 269 | 3,099,418 | Common Stock | |
| William B. Rutherford | CFO and EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 8,821 | 72,968 (0%) | 0% | 244.1 | 2,153,206 | Common Stock |
| William B. Rutherford | CFO and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 23,980 | 81,789 (0%) | 0% | 0 | Common Stock | |
| Charles J. Hall | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 17,020 | 207,720 (0%) | 0% | 0 | Common Stock | |
| Charles J. Hall | Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 6,082 | 201,638 (0%) | 0% | 244.1 | 1,484,616 | Common Stock |
| Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 414,715 (0%) | 0% | - | Common Stock | |
| Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 0 | - | - | Restricted Stock Units | |
| Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 35,830 | 378,885 (0%) | 0% | 244.1 | 8,746,103 | Common Stock |